About the Company

Getein Biotech, Inc. (stock code:603387), established in 2002, is a fully integrated in vitro diagnostic company that researches and develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits in point-of-care testing (POCT). In July 2017, Getein Biotech got listed on the main board of the Shanghai Stock Exchange.
As a biotechnical company, Getein Biotech has been dedicated to providing excellent in vitro diagnostic service for people from all over the world with our most advanced technology. With great contribution of our advanced R&D center and 19-year continuous development, Getein Biotech has developed 8 technology platforms, including Point-Of-Care Testing (POCT), clinical chemistry, chemiluminescence, hematology, coagulation, urinalysis, molecular diagnostics and raw materials for diagnostic reagents, covering testing fields of cardiovascular disease, kidney injury, diabetes mellitus, gestation, infectious disease, cancer, etc.. Meanwhile, Getein Biotech achieved BSI ISO13485 Quality Management System Certification and CE Certification, ensuring good quality, stability and reliability of the products.
At present, Getein Biotech owns 35 subsidiaries and our business has developed to over 110 countries and regions of all over the world. The market share of Getein Biotech keeps in the first rank in the cardiac POCT market in China. And currently, we serve over 30,000 hospitals in China and countless hospitals in the world.
Taking people's wellbeing as the motivation of our continuous development, Getein Biotech is dedicated to becoming an international competitive biological technological company and contributes to people's health in the world. That’s our commitment to helping people from different countries live a happy and well life.





Our mission to "pursue excellence and deliver health” means a commitment to keep patients’ wellbeing in mind. We strive to deliver high-quality, reliable, and affordable point-of-care and diagnostic solutions to professional clinical laboratories, hospitals, and physician offices. Our commitment is backed by our quality first policy, talented team, innovative technology and accountability attitude.